A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

Por Wong, Nan Soon, Fernando, Nishan H., Bendell, Johanna C., Morse, Michael A., Blobe, Gerard C., Honeycutt, Wanda, Pang, Herbert, Hurwitz, Herbert I.
Publicado em 2011

Phase I Dose Escalation Study of Gemcitabine plus Irinotecan in Advanced Solid Tumors

Por Dugan, Elizabeth, Truax, Roxanne, Meadows, Kellen L., Blobe, Gerard C., Morse, Michael A., Fernando, Nishan H., Gockerman, Jon P., Petros, William P., Hurwitz, Herbert I.
Publicado em 2009

A Phase I Dose-Escalation Study of Imatinib Mesylate (Gleevec/STI571) plus Capecitabine (Xeloda) in Advanced Solid Tumors

Por Dugan, Elizabeth, Truax, Roxanne, Meadows, Kellen L., Nixon, Andrew B., Petros, William P., Favaro, Justin, Fernando, Nishan H., Morse, Michael A., Blobe, Gerard C., Hurwitz, Herbert I.
Publicado em 2010

A Phase II study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer

Por WONG, NAN SOON, FERNANDO, NISHAN H., NIXON, ANDREW B., CUSHMAN, STEPHANIE, AKLILU, MEBEA, BENDELL, JOHANNA C., MORSE, MICHAEL A., BLOBE, GERARD C., ASHTON, JILL, PANG, HERBERT, HURWITZ, HERBERT I.
Publicado em 2011